Carbamazepine-induced hepatitis;Karbamazepinindusert hepatitt

Tidsskrift for den Norske Laegeforening

Volumn 120, Issue 24, 2000, Pages 2875-2877

  Haukeland, John Willy ^b   Jahnsen, Jørgen ^b   Raknerud, Nils ^b  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG METABOLISM; HUMAN; LIVER TOXICITY; MALE; MEDICAL RECORD; PATHOPHYSIOLOGY; PROGNOSIS; TOXIC HEPATITIS;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; CASE REPORT; ENGLISH ABSTRACT; FEMALE; HEPATITIS, TOXIC; HUMAN; LIVER; MALE; MIDDLE AGE; PROGNOSIS;

EID: 0034633675     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Knudsen L, Jensen KB. Medikamentel hepatitis. En oversigt - og et tilfelde udløst af karbamazepin (Tegretol). Ugeskr Læger 1979; 141: 3160-3.
2. Levander HG. Granulomatous hepatitis in a patient receiving carbamazepine. Acta Med Scand 1980; 208: 333-5.
3. Zucker P, Daum F, Cohen MI. Fatal carbamazepine hepatitis. J Pediatr 1977; 91: 667-8.
4. Hopen G, Nesthus I, Lærurn OD. Fatal carbamazepine-associated hepatitis. Report of two cases. Acta Med Scand 1981; 210: 333-5.
5. Forbes GM, Jeffrey GP, Shilkin KB, Reed WD. Carbamazepine hepatotoxicity: another cause of the vanishing bile duct syndrome. Gastroenterology 1992; 102: 1385-8.
6. Horowitz S, Patwardhan R, Marcus E. Hepatotoxic reactions associated with carbamazepine therapy. Epilepsia 1988; 29: 149-54.
7. Hadzic N, Portmann B, Davies ET, Mowat AP, Mieli-Vergani G. Acute liver failure induced by carbamazepine. Arch Dis Child 1990; 65: 315-7.
8. Stricker BHC, Biour M, Wilson JHP. Individual agents: drugs. I: Stricker BHC, red. Drug-induced hepatic injury. 2. utg. Amsterdam: Elsevier, 1992.
9. Pessayre D. Mechanisms of drug-induced hepatic injury. I: Stricker BHC, red. Drug-induced hepatic injury. 2. utg. Amsterdam: Elsevier, 1992.
10. Pirmohamed M, Kitteringham NR, Breckenridge AM, Park BK. Detection of an autoantibody directed against human liver microsomal protein in a patient with carbamazepine hypersensitivity. Br J Clin Pharmacol 1992; 33: 183-6.
11. Sherlock S, Dooley J. Diseases of the liver and biliary system. 9. utg. Oxford: Blackwell Scientific Publications, 1993.
12. Lee WM. Drug-induced hepatotoxicity. N Engl J Med 1995; 333: 1118-27.
13. Spigset O. Legemiddelutløste leverskader. Tidsskr Nor Lægeforen 1998; 118: 2805-8.
14. Vennerød AM. Norsk Legemiddelhåndbok 1998-99 for helsepersonell. Oslo: Norsk Legemiddelhåndbok I/S, 1998.
15. Larrey D, Pageaux GP. Genetic predisposition to druginduced hepatotoxicity. J Hepatol 1997; 26 (suppl 2): 12-21.
16. Shear NH. Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 1988; 82: 1826-32.